Clinical Trials Browser

Phase 1/2 × brexucabtagene autoleucel × Clear all

NCT02625480 2026-04-09

ZUMA-4

Phase 1/2 Completed

Recurrence, Lymphoma, B-Cell

NCT02614066 2024-11-19

ZUMA-3

Phase 1/2 Completed

125 enrolled 27 charts 2 FDA

Recurrence